News Hub | News Direct

All Industries


Article thumbnail News Release

Linqto’s Platform Provides Interested Investors With True Access To Pre-IPO Companies

Benzinga

By Kyle Anthony, Benzinga For most investors, investable assets include public equities, bonds, real estate and even precious metals, such as gold. However, even though they can be lucrative as early-stage investments, private equity investments are not considered part of the investment opportunity for most due to their high capital requirements and limited access. Linqto is looking to change the investment landscape for retail investors by making investing in private companies as easy and accessible as investing in the public stock market. In doing this, they are widening the investment opportunities available to investors, enabling them to become beneficial participants in the potentially phenomenal growth pre-Initial Public Offering (IPO) firms can experience, resulting in them garnering investment returns beyond what is usually attainable in public markets. Accessing Private Market Investment With Linqto With companies in recent times staying private for longer, the opportunity for retail investors to access companies reshaping industries, commerce and societal engagement is regularly decreasing as the leaders of these organizations opt to delay entering public markets. With the wellspring of capital available to these firms through angel investors, venture capital firms and private equity institutions, there is no sense of urgency or enthusiasm to become public entities. As such, the economic benefit that these firms derive from their business model benefits a select few. Linqto’s investment platform provides retail investors access to high-growth, technology-driven companies that the firm believes will go public or be acquired within 5 years. Linqto conducts in-depth due diligence on the firms it includes on its platform as it invests alongside its investors. By investing first and ensuring that Linqto has skin in the game, the firm can streamline the investment process, making it as easy as pointing and clicking to participate in the investment opportunities presented on their platform. Its focus is on mid-to-late-stage private companies within the technology industry, where selected firms must be generating a minimum revenue with institutional venture capital or private equity investor backing. Finally, Linqto’s fee structure is a true differentiator, as it is a zero-fee investment management platform. Given that Linqto purchases shares in large quantities from founders, employees and investors, it receives these shares at a negotiated price. Linqto can then make smaller quantities of its shareholdings available to investors at a reasonable markup, thus eliminating the need for further follow-on fees for the investor. Linqto’s Investment Platform versus Other Self-Directed Investment Platforms Linqto’s investment platform is solely dedicated to private, pre-IPO investing; once a company on its platform enters the public market, it will transfer the now-public, registered shares of stock into an investor’s brokerage account. The difference in Linqto’s value proposition is highlighted when contrasted against other self-directed investment platforms. Recently, Charles Schwab Corp. (NYSE: SCHW) announced it would launch a self-directed alternative investments platform for qualified individual investors with assets of more than $5 million. The platform will offer investors access to private equity, venture capital, private credit and long-short exchange funds. Linqto’s approach vastly differs from Charles Schwab's, as its initial minimum investment amount is just $2,500, with subsequent investment amounts being $5,000. Furthermore, Linqto’s platform provides investors access to full equity ownership in companies – not private equity funds. It is important to note that you must be an accredited investor to invest on the platform.* The difference is even more evident when contrasting Linqto with Robinhood (NASDAQ: HOOD), the popular commission-free stock trading and investing app. Robinhood allows users to invest in publicly traded investment offerings, not pre-IPO offerings. Though Robinhood does allow for ‘pre-IPO orders,’ this is not the same as investing in pre-IPO investments; it is merely Robinhood providing the convenience of entering investor orders before the morning of the IPO. They cannot execute an order until the stock begins officially trading publicly. Historically, investing in a private company required individuals to invest at least $100,000. Though firms such as Forge Global Holdings (NYSE: FRGE), EquityZen and HIIVE facilitate pre-IPO investing, Linqto says its fee structure is more advantageous to retail investors desiring access to private investment opportunities. Utilizing Linqto To Access Private Investment Opportunities For retail investors who have been unable to add non-public investments to their portfolio due to high minimum investments and restrictive fee structures, Linqto is revolutionizing the investment journey in the private market by making it affordable, accessible and easy. As companies remain private longer, attaining operational scale and achieving significant revenue growth year over year, their investors benefit from the phenomenal growth these firms may experience, resulting in them garnering investment returns far beyond what is usually attainable in public markets. Linqto desires to provide this opportunity to retail investors through their platform, broadening their investment opportunity set and giving them access to tremendous wealth generation. Click here to visit the Linqto website and begin your private investing journey. *In the United States, an accredited investor is someone who has earned $200,000 in gross income the last two years ($300,000 if filing with a spouse or partner), someone who has a net worth of $1,000,000 aside from their primary residence, or someone who holds a valid FINRA Series 7, 65, or 82 license. Featured photo by Joshua Mayo on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 29, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today that its Seattle Campus completed a new commercial milestone for regulatory compliance in 2024. The site supported a multi-product inspection in March 2024 with the Food and Drug Administration (FDA) to support Biologics License Applications (BLA) for new products seeking commercial approval in the U.S., two of which are now approved for commercial production at the facility. The two approved products include a fusion protein-based drug for treating bladder cancer and a monoclonal antibody (mAb) for treating macular degeneration. AGC Biologics Seattle predicts delivering multiple batches per year for the biopharma partners that received the approvals and accommodating increases in future demand. “This achievement is significant for this site, our team members and our partners in the pharmaceutical industry seeking to bring products from clinical stages to commercial approval,” notes Michael Tranmer, General Manager of AGC Biologics Seattle. “Inspections for multiple products at one time is not easy. This accomplishment is a true testament to our commitment to quality and regulatory compliance and helping developers reach their goals as fast and efficiently as possible.” This is the latest achievement for the Seattle-based CDMO manufacturing site, which has produced six commercial products for AGC Biologics. This includes three commercial approvals in the last two years. AGC Biologics Seattle is active in helping clients navigate clinical milestones, as well. The site team is working with several clinical-stage companies and predicts more commercial license application submissions in the coming 18 to 24 months. AGC Biologics runs multiple mammalian cGMP manufacturing lines and a variety of scales at its Seattle site. The campus serves as a center of excellence for formulation and employs the latest fed-batch and perfusion manufacturing processes. Over the last year, AGC Biologics Seattle has also expanded. This work includes a new microbial-based manufacturing line system and a state-of-the-art 67,000 sq. ft. GMP-compliant warehouse to further enhance the quality, efficiency and operational excellence of the site. To learn more about AGC Biologics’ protein biologics manufacturing site in Seattle, visit www.agcbio.com/facilities/seattle. For more information on the company’s end-to-end global CDMO services in the U.S., Europe, and Japan visit www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

July 29, 2024 05:30 AM Pacific Daylight Time

Article thumbnail News Release

GCC Advisors Announces Strategic Initiatives to Enhance Global Business Expansion Services

Rev Up Marketers

GCC Advisors, led by seasoned industry experts Manuel Manzoni and Marco Scardeoni, is proud to announce a series of strategic initiatives aimed at bolstering support for businesses pursuing international expansion. With a commitment to transparency, integrity, and excellence, GCC Advisors is dedicated to providing businesses with the confidence and tools necessary to navigate the complexities of global markets successfully. A key aspect of these initiatives is enhancing transparency in client relationships. GCC Advisors places a strong emphasis on ensuring clients are well-informed at every stage of their international expansion journey. The firm’s approach includes detailed consultations, clear communication, and continuous support, fostering an environment of trust and confidence. This initiative aims to streamline the expansion process, providing businesses with the clarity needed to make informed decisions. Under the leadership of Manuel Manzoni and Marco Scardeoni, GCC Advisors upholds the highest standards of integrity. The firm adheres to stringent ethical standards, prioritizing honesty, fairness, and accountability in all client interactions. This commitment to integrity not only strengthens client relationships but also reinforces GCC Advisors' reputation as a reliable and credible partner in the industry. Photo Credit: Manuel Manzoni & Marco Scardeoni GCC Advisors is dedicated to delivering excellence in service offerings. The firm’s comprehensive services—from strategic planning to implementation—are designed to achieve superior results that exceed client expectations. This focus on high-quality service ensures that clients receive the best possible support for their international expansion efforts. Recognizing the challenges of entering foreign markets, GCC Advisors leverages its extensive expertise to guide clients through the complexities of international business. With a deep understanding of global market dynamics, GCC Advisors provides tailored solutions that address specific client needs, ensuring a smooth and successful expansion process. GCC Advisors adopts a personalized approach by developing customized strategies that align with each client’s unique objectives and challenges. This tailored methodology allows GCC Advisors to offer targeted solutions that drive success, enhancing client satisfaction and building long-term trust. To ensure continuity of core business operations during international expansion, GCC Advisors focuses on maximizing efficiency and minimizing disruption. The firm’s streamlined processes enable businesses to maintain operational stability while pursuing growth opportunities abroad. Fostering long-term partnerships is a key priority for GCC Advisors. Manuel Manzoni and Marco Scardeoni view each client engagement as a collaborative journey toward mutual success. By providing ongoing support and strategic guidance, GCC Advisors becomes a trusted advisor and partner, committed to helping businesses thrive in the global marketplace. GCC Advisors values client feedback as a critical component of continuous improvement. By actively seeking and incorporating client input, GCC Advisors ensures its services remain at the forefront of industry trends and best practices. This commitment to innovation drives ongoing enhancement of the firm’s value proposition. With these strategic initiatives, GCC Advisors reaffirms its dedication to supporting businesses in their global expansion endeavors. By maintaining a focus on transparency, integrity, and excellence, GCC Advisors provides clients with the assurance and expertise needed to succeed in international markets. For more information about GCC Advisors and their services, visit https://gcc-advisors.com/. About GCC Advisors GCC Advisors is a leading consultancy firm specializing in global business expansion services. With a team of experienced professionals, the company offers strategic planning, market analysis, and tailored solutions to help businesses successfully navigate international markets. Committed to excellence and integrity, GCC Advisors provides comprehensive support to ensure seamless expansion and long-term success for its clients. Contact Information: GCC Advisors GCC Advisors S.r.l. Via Papa Giovanni XXIII, 67 25015 Desenzano del Garda (BS), Lombardy, Italy Email: info@gccadvisorssrl.com Website: https://gcc-advisors.com/ Contact Person: Manuel & Marco Contact Details GCC Advisors Manuel & Marco info@gccadvisorssrl.com Company Website https://gcc-advisors.com/

July 29, 2024 07:43 AM Eastern Daylight Time

Image
Article thumbnail News Release

KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment

RazorPitch KDLY

Amidst the ongoing opioid crisis, which has prompted increasing scrutiny of traditional pain treatments, there is a growing recognition of the need for comprehensive and effective approaches to pain relief. This shift is creating a market for innovative solutions that integrate conventional medical practices with alternative therapies, such as medical cannabis. As more patients and providers seek to navigate the complexities of pain management, the landscape is evolving rapidly, paving the way for new opportunities in healthcare delivery. KindlyMD, Inc. (NASDAQ: KDLY) has emerged as a pioneer in integrating traditional primary care with alternative pain management strategies. Founded on a patient-first philosophy, KindlyMD operates four centers, including the largest alternative pain treatment center in Utah. The company combines primary care, pain management, behavioral therapy, and alternative treatments, including medical cannabis recommendations, to offer comprehensive care and reduce opioid dependency. Financial Milestones and Market Presence KDLY announced the closing of its IPO of 1,240,910 units at $5.50 per unit, raising approximately $6.8 million in gross proceeds back in early June. This financial boost positions KindlyMD to execute its growth strategy effectively. Additionally, KindlyMD has made significant strides in becoming the first alternative medical treatment company in Utah to contract with the state's top insurance payors, including Select Health, Medicare, Medicaid, and Blue Cross Blue Shield, covering nearly 80% of Utah's population. "This is a major milestone for KindlyMD," said Tim Pickett, PA-C, founder and CEO of KindlyMD. "Now, the scope of services we provide at our Company-branded clinics, including behavioral healthcare and medical interventions incorporating alternative medicine, are covered by and reimbursable by the largest insurance providers across the state." Addressing the Opioid Crisis Provisional data from the CDC's National Center for Health Statistics indicates that in 2021, nearly 108,000 people died of drug overdose in the U.S., with over 80,000 of these deaths attributed to opioids. The government has responded with the largest opioid treatment grant funding ever. Despite widespread use of prescription medication among Americans aged 45-64, many of these prescriptions are insufficient and carry significant long-term side effects. KindlyMD is addressing this crisis head-on by offering non-opioid treatment options like medical cannabis, which have become more widespread in recent years. However, these options are often excluded from clinical recommendations and guidelines, creating an unmet need that KindlyMD aims to fill. To date, the company has seen over 60,000 patient visits in its clinics, providing comprehensive care plans that ensure safe use, appropriate dosing, and behavioral health support for those who need opioids. Strategic Collaborations and Community Outreach On June 10, KDLY announced a collaboration with Curaleaf Holdings, Inc., a leading international provider of cannabis products. The two companies are working together to provide educational resources on holistic pain management and treatment options, including medical cannabis. This partnership includes community care events throughout the summer, aiming to enhance patients understanding of holistic pain management "Our innovative collaboration with Curaleaf will provide more patients with access to pain management treatment options and alternative therapies," said Tim Pickett. "As the U.S. government moves toward rescheduling cannabis as a legitimate medicine, this collaboration will help more patients find sustainable, safer, and more affordable healthcare treatment options." KDLY recently submitted a comment to the U.S. Department of Justice regarding the proposed reclassification of cannabis from Schedule I to Schedule III of the Controlled Substances Act. This reclassification is expected to have several positive impacts on the medical cannabis industry, including reducing patient costs and enabling businesses to deduct standard operating expenses. "Reclassification underscores the continued relevance and importance of our integrated healthcare model," said Tim Pickett. "It will likely lead to increased access and utilization of medical cannabis among our patients, benefiting KindlyMD through improved patient outcomes, new educational opportunities, and enhanced financial stability." Federal Funding Initiatives KindlyMD's successful registration on SAM.gov, the official U.S. federal funding platform, marks a significant milestone for the company. This registration enables KindlyMD to obtain federal grants and contracts, including those with the Department of Veterans Affairs, to support its mission of providing comprehensive healthcare solutions. Following its registration, KindlyMD submitted its first grant application for the USDA Rural Utilities Service Distance Learning and Telemedicine Grant Program, seeking $1,000,000 to expand its Complete Care telehealth program in rural communities in Utah. This program aims to deliver effective healthcare through an interconnected network of telemedicine clinics, addressing the unique challenges faced by rural populations. Financial Performance For the quarter ended March 31, 2024, KDLY reported revenues of $829,029, a decrease compared to the previous year, primarily due to a shift towards insurance billing. However, the company began receiving reimbursements from insurance payors for the first time in its history during this period, amounting to $34,722. Operating expenses decreased by 21.9%, and the company reported a net loss per share decrease of 50%. The capital raised from the IPO will enable KindlyMD to invest in growth opportunities, including mergers and acquisitions of additional clinics in Utah. With over 16% of the medical cannabis patient population in Utah already under its care, KindlyMD is well-positioned to expand its reach and enhance patient outcomes. KindlyMD, Inc.'s (NASDAQ: KDLY) innovative approach and industry expertise position it uniquely to continue providing unique healthcare services. As the regulatory landscape evolves, KDLY remains a crucial partner for patients seeking alternative and integrative healthcare solutions, particularly in the ongoing battle against the opioid epidemic. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700

July 29, 2024 06:00 AM Eastern Daylight Time

Article thumbnail News Release

Text Patents a Method for Combining Asynchronous and Real-Time Communication

Text, Inc.

Text, a global leader in B2B text communication solutions, has secured its fifth patent in the United States. The patented "system and method" enables the seamless integration of asynchronous communication channels with real-time communication within a single platform. "Customers want to communicate with companies in various ways. Sometimes, an email or another method that allows the recipient to respond later is best, which is asynchronous communication. However, sometimes rapid, direct, real-time interaction is necessary. Our technology enables seamless integration of these communication types, providing real benefits for our clients: increased user satisfaction, faster issue resolution, and better management of existing information, " explains Konrad Kruk, Head of Widget and the patent's author. The patent granted by the United States Patent and Trademark Office (USPTO) describes a system and method that integrates asynchronous messaging with real-time communication, allowing smooth transitions between different communication modes within a single platform. The invention enables users to switch between messages (such as emails or SMS) and real-time interactions (such as voice or video calls) without leaving the communication platform or starting a new session. "This is our fifth patent, confirming our position as one of the technological innovators in the industry. We are especially proud because the secured solution introduces significant improvements in online communication, ensuring companies maintain uninterrupted and consistent communication with customers across various industries, " said Katarzyna Rogowska, head of Text's legal department. The key benefits of the newly patented solution for Text's clients and end-users include: - Improved communication efficiency: Combining asynchronous messaging with real-time communication on one platform reduces the need to switch between different communication tools, saving time and increasing productivity. - Enhanced user experience: Internet users communicating with companies via solutions like LiveChat can enjoy seamless communication, effortlessly transitioning between messaging and real-time conversations. This particularly benefits customer service, remote work, and collaborative projects. - Increased accessibility: The unified interface makes managing communications easier, ensuring that important messages and real-time interactions are never missed. This is particularly useful in environments where timely communication is critical. - Easier and more efficient record-keeping: The synchronization feature ensures that all communications are recorded, providing a reliable record of interactions. This can be crucial for legal, compliance, and reference purposes. - Scalability and flexibility: The system can be scaled to suit different organizational sizes and integrated with other systems, making it a flexible solution for various industries and applications. In summary, the invention registered by the USPTO enhances communication by combining the advantages of asynchronous messaging and real-time communication in one coherent system, offering increased efficiency, user experience, and accessibility for individuals and organizations. Operating in the “customer service” business, Text (formerly LiveChat) is one of the leaders in the global market for live chat solutions. Its LiveChat product supports companies in customer service, online sales support, and lead generation—allowing its partners to stay in touch with their customers anywhere and anytime. Text’s other products include ChatBot, HelpDesk, KnowledgeBase, and OpenWidget. LiveChat is used by over 37 thousand companies in 150 countries, the ChatBot product has over 2,800 customers in more than 30 countries, and the Helpdesk product has over 1,000 customers. Contact Details PR Team pr@text.com Company Website https://text.com/

July 29, 2024 05:34 AM Eastern Daylight Time

Article thumbnail News Release

BestGrowthStocks.Com Issues a Comprehensive Analysis of Tivic Health Systems Potential Catalysts

Tivic Health Systems Inc.

NEW YORK, NY / NewsDirect / July 29, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive analysis on Tivic Health Systems Inc. a health tech company that develops and commercializes bioelectronic medicine. Tivic Health Systems Inc. (NASDAQ: TIVC) recently announced the expansion of its intellectual property portfolio with three new patents granted in the US and Europe. Best Growth Stocks full report breaks through the noise and offers an extensive comprehensive analysis of Tivic Health Systems operations, potential catalysts, pipeline, patents, share structure, recent news events, growth strategy, financials, chart support and resistance zones, and more. Access this full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/ Access the full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/ About Tivic Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Tivic’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.com Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

July 29, 2024 04:25 AM Eastern Daylight Time

Image
Article thumbnail News Release

Trust Stamp and Botdoc Forge Strategic Partnership to Enhance Automotive Security

T Stamp Inc

Trust Stamp President Andrew Gowasack and Karl Falk, CEO of Botdoc joined Steve Darling from Proactive to announce an exciting new partnership. The collaboration aims to integrate Trust Stamp’s low-code Orchestration Platform into Botdoc Connect product, enhancing Identity Verification and Know Your Customer processes. This integration will include document validation using the Driver License Data Verification System provided by the American Association of Motor Vehicle Administrators. Trust Stamp has obtained a license from AAMVA to access this system, ensuring accurate and reliable identity verification. Trust Stamp and Botdoc have a history of working together in various industries, including banking, lending, and insurance. Both companies are graduates of the Independent Community Bankers of America ThinkTECH accelerator. They have observed a growing trend of criminals using counterfeit or altered driver's licenses, driving permits, and ID cards to commit fraud. With nearly 80,000 cars stolen from dealerships in the past year, the need for robust identity document validation is more critical than ever. Through this partnership, Botdoc customers will be empowered to combat fraud more effectively. Trust Stamp’s low-code Orchestration Layer platform offers a variety of solutions, including the real-time capability to verify driver's license and ID information against data from the issuing agency. This feature significantly enhances the security and reliability of identity verification processes, helping businesses protect themselves and their customers from fraudulent activities. The integration of Trust Stamp’s advanced technology into Botdoc's Connect product represents a significant step forward in the fight against identity fraud. It underscores both companies' commitment to leveraging innovative solutions to address complex challenges in the digital age. Contact Details Proactive USA +1 347-449-0879 na-editorial@proactiveinvestors.com

July 26, 2024 10:22 AM Eastern Daylight Time

Video
Article thumbnail News Release

First Phosphate Corp ends Drill Program plans Upcoming Resource Estimate at Bégin-Lamarche Project

First Phosphate Corp

First Phosphate Corp CEO John Passalacqua Chief Geologist Gilles Laverdiere joined Steve Darling from Proactive to announce that all results from the drilling program at its Bégin-Lamarche project are now available. The 99-hole drill program, totaling 25,929 meters, has uncovered a significant high-quality igneous phosphate deposit. The drilling has shown continuous phosphate mineralization over a length of 2,400 meters, spread across three mineralized zones. Laverdiere explained that a NI 43-101 resource estimate is currently underway and will be immediately followed by a Preliminary Economic Assessment. A total of 23 drill holes were completed in the Mountain Zone, totaling 5,023 meters. The Mountain Zone exhibits grades of more than 10% P2O5 over widths ranging from 7 meters to 99 meters. In the Southern Zone, drilling was conducted at 100-meter spaced sections over a length of 1,700 meters, with 57 drill holes totaling 15,219 meters. Passalacqua says the company anticipates having the resource estimate completed in the coming months, marking a significant milestone in the project's development. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

July 26, 2024 10:19 AM Eastern Daylight Time

Video
Article thumbnail News Release

All Eyes On Atlas Lithium As The US Assistant Secretary Of State For Energy Resources Visits The Company's Headquarters In Brazil

Benzinga

By Mangeet Kaur Bouns, Benzinga In a strategic move that underscores the growing importance of critical minerals in defense and national security, Atlas Lithium Corporation (NASDAQ: ATLX) hosted a delegation of U.S. diplomats at its corporate office in Belo Horizonte, the mining capital of Brazil. This recent visit, led by Ambassador Geoffrey Pyatt, U.S. Assistant Secretary of State for Energy Resources, highlights the rising recognition of Atlas Lithium’s rapidly developing lithium project. Atlas Lithium’s strategic initiatives in Brazil are not just pivotal for the company but also play a crucial role in the broader context of U.S. efforts to reduce dependence on foreign sources for these vital materials. The expansion of Atlas Lithium’s exploration footprint in Brazil, now encompassing nearly 539 km² (208 square miles) highlights the potential of this region as a significant contributor to the global supply chain of critical minerals. As the world transitions to a greener energy mix, the demand for these minerals is set to skyrocket. Minerals That Are Critical To Evolving Markets Critical minerals like lithium and copper will play pivotal roles over the next few decades in achieving the global energy transition, spurring economic development and strengthening national security. The world is gradually shifting towards a greener energy mix, but this transition demands significant mining resources. According to the International Energy Agency (IEA), the demand for critical minerals in clean energy could surge by as much as six times by 2040, with the low-carbon energy generation sector's demand tripling. Mining and processing these critical minerals are essential for sustaining the military’s technological edge, securing manufacturing supply chains and advancing sustainable development practices. The United States Geological Survey (USGS) has identified 50 critical minerals essential to the economic and national security of the U.S. The Department of Defense (DOD) has identified over 250 strategic and critical materials that support military and essential civilian industries. Mining will thus play a vital role in economic development. The global mining market size is expected to grow from $2.14 trillion in 2023 to $2.28 trillion in 2024, at a CAGR of 6.5% and will further expand to $2.83 trillion by 2028 at a CAGR of 5.5%. The mining sector in the U.S. employs over half a million individuals and contributed 1.4% to the GDP last year. However, the U.S. has become increasingly import-dependent for its supply of these critical minerals, particularly rare earth elements (REEs), which are vital for various defense applications. US Efforts To Secure Critical Minerals As A Matter Of National Security The strategic importance of mining and processing critical minerals extends beyond environmental sustainability; they are crucial to national security and economic development. Yet, the U.S. relies heavily on imports, which may pose risks to its defense capabilities and economic stability. Since the early 2000s, the U.S. has increasingly relied on imports for its supply of rare earth oxides. China’s dominance in producing and processing critical minerals may exacerbate these risks, as highlighted by recent geopolitical tensions and trade restrictions. China accounts for 63% of the world’s rare earth mining and holds the largest reserves of REEs, around 44 million metric tons as of 2023. In contrast, the U.S. ranks seventh, with 1.8 million metric tons. To mitigate these vulnerabilities, the U.S. government is focusing on securing supply chains through partnerships and investments in countries rich in critical minerals. With its substantial reserves of copper, lithium and other critical minerals, Latin America is emerging as a key region for such investments. Brazil, for instance, has the third-largest reserves of rare earths at a staggering 21 million metric tons. US Diplomatic Visit Highlights Strategic Importance U.S. diplomats’ recent visit to Atlas Lithium’s main operational office in Brazil is a natural consequence of the government’s effort to secure critical minerals. The delegation included Ambassador Geoffrey Pyatt, U.S. Assistant Secretary of State for Energy Resources; Benjamin Burnes, Energy Officer for South America; Renato Barreda, Economic Officer, Mining and Critical Minerals; Katherine Ordonez, U.S. Consul; and Tulio Teixeira, Commercial Specialist, Mining Sector. This visit represents the strengthening ties between the U.S. and Brazil in the realm of critical minerals. It highlights the strategic importance of Atlas Lithium’s extensive project portfolio and reinforces the U.S. government’s commitment to securing its critical mineral supply chains through international collaboration. The Broader Implications Of Securing Critical Minerals Securing critical minerals is not just about economic interests but also about maintaining technological and military superiority. The mining and processing of critical minerals underpin various defense applications, from advanced weaponry to essential civilian technologies. The concentration of these mineral resources in geopolitically sensitive areas adds a layer of complexity to national security strategies. This necessitates a delicate balance between securing sufficient supplies and maintaining diplomatic relations. Atlas Lithium’s strategic positioning in Brazil’s prolific Lithium Valley, combined with its extensive portfolio of critical mineral rights, uniquely positions the company to meet the surging demand for these strategic resources. With such a large land area dedicated to lithium exploration and with ownership of mineral rights for many other critical minerals, Atlas Lithium is well-equipped to support the clean energy transition and contribute significantly to various industrial applications in the future. The recent visit of U.S. diplomats to Atlas Lithium underscores the increasing recognition of the company’s critical mineral projects and the broader U.S. strategy to secure these essential resources. With the role of critical minerals growing substantially in importance, such international partnerships and alliances are crucial for U.S. national security, economic development and environmental sustainability. Featured photo by Dion Beetson on Unsplash Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 26, 2024 08:45 AM Eastern Daylight Time

Image
1 ... 131132133134135 ... 3797